Lumito presents at Financial Stockholm on the 21st of October
Kurs
-16,67%
Likviditet
0,19 MSEK
Prenumeration
Kalender
| Est. tid* | ||
| 2026-05-07 | N/A | Årsstämma |
| 2026-05-07 | 08:30 | Kvartalsrapport 2026-Q1 |
| 2026-02-20 | 08:30 | Bokslutskommuniké 2025 |
| 2025-10-30 | 08:30 | Kvartalsrapport 2025-Q3 |
| 2025-10-10 | - | Extra Bolagsstämma 2025 |
| 2025-08-11 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-08 | - | X-dag ordinarie utdelning LUMITO 0.00 SEK |
| 2025-05-07 | - | Årsstämma |
| 2025-05-07 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-20 | - | Bokslutskommuniké 2024 |
| 2024-10-31 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-23 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-08 | - | X-dag ordinarie utdelning LUMITO 0.00 SEK |
| 2024-05-07 | - | Årsstämma |
| 2024-05-07 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-22 | - | Bokslutskommuniké 2023 |
| 2023-10-31 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-17 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-26 | - | X-dag ordinarie utdelning LUMITO 0.00 SEK |
| 2023-05-25 | - | Årsstämma |
| 2023-05-03 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-23 | - | Bokslutskommuniké 2022 |
| 2022-11-02 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-18 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-30 | - | X-dag ordinarie utdelning LUMITO 0.00 SEK |
| 2022-05-27 | - | Årsstämma |
| 2022-05-06 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-24 | - | Extra Bolagsstämma 2021 |
| 2021-10-20 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-18 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-28 | - | X-dag ordinarie utdelning LUMITO 0.00 SEK |
| 2021-05-27 | - | Årsstämma |
| 2021-04-28 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-17 | - | Bokslutskommuniké 2020 |
| 2020-11-03 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-20 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-28 | - | X-dag ordinarie utdelning LUMITO 0.00 SEK |
| 2020-05-27 | - | Årsstämma |
| 2020-04-28 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-17 | - | Bokslutskommuniké 2019 |
| 2019-10-31 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-21 | - | Kvartalsrapport 2019-Q2 |
| 2019-06-04 | - | Årsstämma |
| 2019-05-23 | - | X-dag ordinarie utdelning LUMITO 0.00 SEK |
| 2019-04-30 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-15 | - | Bokslutskommuniké 2018 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Nordic SME Sweden |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Lumito AB (publ) ("Lumito" or the "Company") is currently conducting a rights issue, with a subscription period ending on the 30th of October 2025. Lumito's CEO, Sanna Wallenborg, will present the Company, the rights issue, and future plans at Financial Stockholm's event at Hotel Scandic Anglais in Stockholm on the 21st of October 2025.
Financial Stockholm
Date and time: 21st of October 2025, 5:20-8:00 p.m. (Lumito's presentation is at 5:30-5:50 p.m.).
Location: Scandic Anglais, Stockholm.
Register here.
The event will be filmed and made available on the Company's website afterwards.
For details about the ongoing rights issue, click here.
For further information, please contact:
Sanna Wallenborg, CEO Lumito
E-mail: sw@lumito.se
Ph: +4670-870 01 68
About Lumito
Lumito specialises in medical technology and translational research in digital tissue imaging. Lumito offers a groundbreaking, highly sensitive imaging technique to locate and measure protein biomarkers in tissue samples using up-converting nanoparticles (UCNPs) through its patented research platform. The technology combines image data with precise biomarker detection, enabling images with higher contrast where irrelevant background information is filtered out. The technique can enhance the analysis of tissue samples by increasing objectivity, thereby contributing to research for more quantifiable diagnoses and optimised treatments. Lumito primarily focuses on drug development and digital pathology and is a spin-off from a research group at Lund University's Department of Atomic Physics and Laser Center. www.lumito.se/en/
The share is traded on NGM Nordic SME under the name LUMITO, and Mentor is Mangold Fondkommission.